CFDE Data Portal | Search EIF3EP1

	Label	Description
	EIF3EP1 associations Collection (Entity type)	Associations for EIF3EP1_associations
	EIF3EP1 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	EIF3EP1 Gene (Entity type)	ENSG00000234882 - EIF3E pseudogene 1
	GSE216273 GSE216292 palbociclib 14 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE236502 paclitaxel 2 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE238018 MXRA8 knockout MDA-MB-231 3 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE246325 PRMT5 inhibition 1 v 4 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE235066 carboplatin 7 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE155031 catechin SH-SY5Y 5 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE228357 OGA knockdown 3 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS

EIF3EP1 associations

Associations for EIF3EP1_associations

EIF3EP1 associations.tsv

A file from IDG as part of the Harmonizome project

EIF3EP1

ENSG00000234882 - EIF3E pseudogene 1

GSE216273 GSE216292 palbociclib 14 v 1 human dn

A Gene Set from LINCS

GSE236502 paclitaxel 2 v 3 human up

A Gene Set from LINCS

GSE238018 MXRA8 knockout MDA-MB-231 3 v 2 human dn

A Gene Set from LINCS

GSE246325 PRMT5 inhibition 1 v 4 human up

A Gene Set from LINCS

GSE235066 carboplatin 7 v 3 human dn

A Gene Set from LINCS

GSE155031 catechin SH-SY5Y 5 v 1 human dn

A Gene Set from LINCS

GSE228357 OGA knockdown 3 v 1 human dn

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.